148 related articles for article (PubMed ID: 36357293)
1. A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis.
Cristoferi L; Porta M; Bernasconi DP; Leonardi F; Gerussi A; Mulinacci G; Palermo A; Gallo C; Scaravaglio M; Stucchi E; Maino C; Ippolito D; D'Amato D; Ferreira C; Nardi A; Banerjee R; Valsecchi MG; Antolini L; Corso R; Sironi S; Fagiuoli S; Invernizzi P; Carbone M
Dig Liver Dis; 2023 Mar; 55(3):373-380. PubMed ID: 36357293
[TBL] [Abstract][Full Text] [Related]
2. Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis.
Cazzagon N; El Mouhadi S; Vanderbecq Q; Ferreira C; Finnegan S; Lemoinne S; Corpechot C; Chazouillères O; Arrivé L
JHEP Rep; 2022 Nov; 4(11):100577. PubMed ID: 36277957
[TBL] [Abstract][Full Text] [Related]
3. Differentiating pediatric autoimmune liver diseases by quantitative magnetic resonance cholangiopancreatography.
Gilligan LA; Trout AT; Lam S; Singh R; Tkach JA; Serai SD; Miethke AG; Dillman JR
Abdom Radiol (NY); 2020 Jan; 45(1):168-176. PubMed ID: 31422438
[TBL] [Abstract][Full Text] [Related]
4. A Quantitative Magnetic Resonance Cholangiopancreatography Metric of Intrahepatic Biliary Dilatation Severity Detects High-Risk Primary Sclerosing Cholangitis.
Selvaraj EA; Ba-Ssalamah A; Poetter-Lang S; Ridgway GR; Brady JM; Collier J; Culver EL; Bailey A; Pavlides M
Hepatol Commun; 2022 Apr; 6(4):795-808. PubMed ID: 34802195
[TBL] [Abstract][Full Text] [Related]
5. A composite score using quantitative magnetic resonance cholangiopancreatography predicts clinical outcomes in primary sclerosing cholangitis.
Vuppalanchi R; Are V; Telford A; Young L; Mouchti S; Ferreira C; Kettler C; Gromski M; Akisik F; Chalasani N
JHEP Rep; 2023 Oct; 5(10):100834. PubMed ID: 37663118
[TBL] [Abstract][Full Text] [Related]
6. Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis.
Grigoriadis A; Imeen Ringe K; Bengtsson J; Baubeta E; Forsman C; Korsavidou-Hult N; Rorsman F; Nilsson E; Kartalis N; Bergquist A
JHEP Rep; 2022 Dec; 4(12):100595. PubMed ID: 36444388
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of quantitative MRCP (MRCP+) for risk stratification of primary sclerosing cholangitis: comparison with morphological MRCP, MR elastography, and biochemical risk scores.
Ismail MF; Hirschfield GM; Hansen B; Tafur M; Elbanna KY; Goldfinger MH; Ridgway GR; Jhaveri KS
Eur Radiol; 2022 Jan; 32(1):67-77. PubMed ID: 34231037
[TBL] [Abstract][Full Text] [Related]
8. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.
Venkatesh SK; Welle CL; Miller FH; Jhaveri K; Ringe KI; Eaton JE; Bungay H; Arrivé L; Ba-Ssalamah A; Grigoriadis A; Schramm C; Fulcher AS;
Eur Radiol; 2022 Feb; 32(2):923-937. PubMed ID: 34363134
[TBL] [Abstract][Full Text] [Related]
9. Quantitative MRCP and metrics of bile duct disease over time in patients with primary sclerosing cholangitis: A prospective study.
Trivedi PJ; Arndtz K; Abbas N; Telford A; Young L; Banerjee R; Eddowes P; Jhaveri KS; Hirschfield GM
Aliment Pharmacol Ther; 2024 Jun; 59(11):1366-1375. PubMed ID: 38571284
[TBL] [Abstract][Full Text] [Related]
10. Inter-reader agreement of interpretation of radiological course of bile duct changes between serial follow-up magnetic resonance imaging/3D magnetic resonance cholangiopancreatography of patients with primary sclerosing cholangitis.
Grigoriadis A; Morsbach F; Voulgarakis N; Said K; Bergquist A; Kartalis N
Scand J Gastroenterol; 2020 Feb; 55(2):228-235. PubMed ID: 32024405
[No Abstract] [Full Text] [Related]
11. Utility of MRCP in surveillance of primary sclerosing cholangitis associated hepatobiliary malignancy: 15 year experience at a single institution in Ontario, Canada.
Nair AV; Macdonald DB; Kelly EM; Satheesh S; Venugopalan P; Soman DK
Clin Imaging; 2022 Jan; 81():47-53. PubMed ID: 34598005
[TBL] [Abstract][Full Text] [Related]
12. Adult Primary Sclerosing Cholangitis (PSC) subjects have worse biliary disease at diagnosis compared to pediatric PSC subjects.
Kulkarni S; Bhimaniya S; Chi L; Tica S; Alghamdi S; Stoll J; Caudill K; Fleckenstein J
Clin Imaging; 2023 May; 97():7-13. PubMed ID: 36868034
[TBL] [Abstract][Full Text] [Related]
13. The role of imaging in determining prognosis for primary sclerosing cholangitis: A systematic review.
Segal D; Marotta P; Mosli M; Zou G; Feagan BG; Al-Judaibi B
Saudi J Gastroenterol; 2019; 25(3):152-158. PubMed ID: 31044745
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of functional strictures in patients with primary sclerosing cholangitis using hepatobiliary contrast-enhanced MRI: a proof-of-concept study.
Poetter-Lang S; Messner A; Bastati N; Ringe KI; Ronot M; Venkatesh SK; Ambros R; Kristic A; Korajac A; Dovjak G; Zalaudek M; Hodge JC; Schramm C; Halilbasic E; Trauner M; Ba-Ssalamah A
Eur Radiol; 2023 Dec; 33(12):9022-9037. PubMed ID: 37470827
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging features of small-duct primary sclerosing cholangitis.
Kozaka K; Sheedy SP; Eaton JE; Venkatesh SK; Heiken JP
Abdom Radiol (NY); 2020 Aug; 45(8):2388-2399. PubMed ID: 32417935
[TBL] [Abstract][Full Text] [Related]
16. Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitis.
Nguyen L; Cazzagon N; Corpechot C; El Mouhadi S; Lemoinne S; Chazouillères O; Arrivé L
Eur Radiol; 2019 Mar; 29(3):1460-1468. PubMed ID: 30159619
[TBL] [Abstract][Full Text] [Related]
17. Primary sclerosing cholangitis in children: utility of magnetic resonance cholangiopancreatography.
Chavhan GB; Roberts E; Moineddin R; Babyn PS; Manson DE
Pediatr Radiol; 2008 Aug; 38(8):868-73. PubMed ID: 18584166
[TBL] [Abstract][Full Text] [Related]
18. The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis.
Tenca A; Mustonen H; Lind K; Lantto E; Kolho KL; Boyd S; Arola J; Jokelainen K; Färkkilä M
Liver Int; 2018 Dec; 38(12):2329-2339. PubMed ID: 29901259
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis.
Weber C; Kuhlencordt R; Grotelueschen R; Wedegaertner U; Ang TL; Adam G; Soehendra N; Seitz U
Endoscopy; 2008 Sep; 40(9):739-45. PubMed ID: 18698533
[TBL] [Abstract][Full Text] [Related]
20. Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography.
Dave M; Elmunzer BJ; Dwamena BA; Higgins PD
Radiology; 2010 Aug; 256(2):387-96. PubMed ID: 20656832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]